Filtros de búsqueda

Lista de obras de

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

artículo científico publicado en 2016

A Phase II Study of Glembatumumab Vedotin for Metastatic Uveal Melanoma

artículo científico publicado en 2020

A phase 1b/2 study of the BRAF inhibitor encorafenib plus the MEK inhibitor binimetinib in patients with BRAF V600E/K-mutant solid tumors

scientific article published on 15 July 2020

Adjuvant Ipilimumab in High-Risk Uveal Melanoma

artículo científico publicado en 2019

Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy

artículo científico publicado en 2022

B cells and tertiary lymphoid structures promote immunotherapy response

artículo científico publicado en 2020

Calcium-sensing receptor autoantibody-mediated hypoparathyroidism associated with immune checkpoint inhibitor therapy: diagnosis and long-term follow-up

scientific article published on 01 June 2020

Circulating Tumor Cells and Early Relapse in Node-positive Melanoma

artículo científico publicado en 2020

Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy

scientific article published on 12 April 2022

Dose-escalation study of vemurafenib with sorafenib or crizotinib in patients with BRAF-mutated advanced cancers

artículo científico publicado en 2020

First-in-Human Study of Mivebresib (ABBV-075), an Oral Pan-Inhibitor of Bromodomain and Extra Terminal Proteins, in Patients with Relapsed/Refractory Solid Tumors

scientific article published on 16 August 2019

Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients.

artículo científico publicado en 2017

Immune profiling of uveal melanoma identifies a potential signature associated with response to immunotherapy

artículo científico publicado en 2020

Incidence, patterns of progression, and outcomes of preexisting and newly discovered brain metastases during treatment with anti-PD-1 in patients with metastatic melanoma

artículo científico publicado en 2019

Intracranial antitumor activity with encorafenib plus binimetinib in patients with melanoma brain metastases: A case series

scientific article published on 28 October 2019

Nivolumab and Ipilimumab in Metastatic Uveal Melanoma: Results From a Single-Arm Phase II Study

artículo científico publicado en 2020

Obstacles to improving outcomes in the treatment of uveal melanoma.

artículo científico publicado en 2018

Pilot Study of Circulating Tumor Cells in Early-Stage and Metastatic Uveal Melanoma

artículo científico publicado en 2019

The Latest on Uveal Melanoma Research and Clinical Trials: Updates from the Cure Ocular Melanoma (CURE OM) Science Meeting (2019)

scientific article published on 15 October 2020

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda